140 related articles for article (PubMed ID: 26294796)
1. Mutant Cullin causes cardiovascular compromise.
Luft FC
EMBO Mol Med; 2015 Oct; 7(10):1254-6. PubMed ID: 26294796
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
Schumacher FR; Siew K; Zhang J; Johnson C; Wood N; Cleary SE; Al Maskari RS; Ferryman JT; Hardege I; Yasmin ; Figg NL; Enchev R; Knebel A; O'Shaughnessy KM; Kurz T
EMBO Mol Med; 2015 Oct; 7(10):1285-306. PubMed ID: 26286618
[TBL] [Abstract][Full Text] [Related]
3. Pseudohypoaldosteronism Type II Caused by
Wang Q; Cao BY; Su C; Li WJ; Gong CX
Chin Med J (Engl); 2018 Aug; 131(15):1879-1881. PubMed ID: 30058590
[No Abstract] [Full Text] [Related]
4. Pseudohypoaldosteronism type 2: CUL3 mutation confirmed 15 years following initial diagnosis.
Li B; Soule S; Wilkinson T; Florkowski C
Intern Med J; 2022 Apr; 52(4):691-692. PubMed ID: 35419964
[No Abstract] [Full Text] [Related]
5. A case of novel mutation of Cullin 3 gene in pseudohypoaldosteronism type II.
Wang L; Nie M; Guo F; Tian Z; Guo X; Zhang S
J Hypertens; 2022 Jun; 40(6):1239-1242. PubMed ID: 35703886
[TBL] [Abstract][Full Text] [Related]
6. A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.
Tsuji S; Yamashita M; Unishi G; Takewa R; Kimata T; Isobe K; Chiga M; Uchida S; Kaneko K
BMC Nephrol; 2013 Jul; 14():166. PubMed ID: 23902721
[TBL] [Abstract][Full Text] [Related]
7. Familial Hyperkalemic Hypertension Genotype With a Negative Phenotype: A CUL3 Mosaicism.
Ostrosky-Frid M; Chávez-Canales M; Romo M; Grunfeld B; Simsolo R; Segura-Kato Y; Tusié-Luna T; Gamba G
Am J Hypertens; 2020 Mar; 33(3):278-281. PubMed ID: 31802109
[No Abstract] [Full Text] [Related]
8. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
Yoshida S; Araki Y; Mori T; Sasaki E; Kasagi Y; Isobe K; Susa K; Inoue Y; Bomont P; Okado T; Rai T; Uchida S; Sohara E
Clin Exp Nephrol; 2018 Dec; 22(6):1251-1257. PubMed ID: 29869755
[TBL] [Abstract][Full Text] [Related]
9. [Severity of familial hyperkalemic hypertension caused by CUL-3 mutations: a story about kidneys and blood vessels].
Rafael C; Hadchouel J
Med Sci (Paris); 2020 May; 36(5):455-458. PubMed ID: 32452365
[No Abstract] [Full Text] [Related]
10. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
Ferdaus MZ; McCormick JA
Am J Physiol Renal Physiol; 2018 May; 314(5):F915-F920. PubMed ID: 29361671
[TBL] [Abstract][Full Text] [Related]
11. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
[TBL] [Abstract][Full Text] [Related]
12. Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene.
Nakano K; Kubota Y; Mori T; Chiga M; Mori T; Sonoda S; Ueda D; Asakura I; Ikegaya T; Kagawa J; Uchida S; Kubota A
Nephrology (Carlton); 2020 Nov; 25(11):818-821. PubMed ID: 32619053
[TBL] [Abstract][Full Text] [Related]
13. [KLHL3 and CULLIN-3: new genes involved in familial hypertension].
Louis-Dit-Picard H; Hadchouel J; Jeunemaitre X
Med Sci (Paris); 2012; 28(8-9):703-6. PubMed ID: 22920870
[No Abstract] [Full Text] [Related]
14. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
Ferdaus MZ; Miller LN; Agbor LN; Saritas T; Singer JD; Sigmund CD; McCormick JA
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263298
[TBL] [Abstract][Full Text] [Related]
15. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers.
Yavas Abali Z; Yesil G; Kirkgoz T; Cicek N; Alpay H; Turan S; Bereket A; Guran T
Pediatr Nephrol; 2020 Mar; 35(3):405-407. PubMed ID: 31529157
[No Abstract] [Full Text] [Related]
16. Pseudohypoaldosteronism types I and II: little more than a name in common.
Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
[TBL] [Abstract][Full Text] [Related]
17. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases.
Uchida S
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):487-93. PubMed ID: 24992566
[TBL] [Abstract][Full Text] [Related]
18. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
Murthy M; Kurz T; O'Shaughnessy KM
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
[TBL] [Abstract][Full Text] [Related]
19. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.
Lin CM; Cheng CJ; Yang SS; Tseng MH; Yen MT; Sung CC; Lin SH
FASEB J; 2019 Jan; 33(1):1051-1061. PubMed ID: 30148674
[TBL] [Abstract][Full Text] [Related]
20. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
